Skip to content

Pregnancy

Thrombophilia in Pregnancy: Risks, Monitoring and Precautions

Pregnancy naturally strengthens clotting. For expectant mothers with thrombophilia: risks, monitoring plans and treatment options.

8 min · 10 February 2025

Thrombophilia in Pregnancy: Risks, Monitoring and Precautions

Pregnancy is a physiologically programmed period: clotting factors rise, natural inhibitors fall and venous return slows — all to control bleeding at delivery. This raises thrombosis risk in every woman; in thrombophilia carriers the increase is far more pronounced.

Why Does Risk Rise in Pregnancy?

  • Clotting factors (fibrinogen, VII, VIII, von Willebrand) rise steadily throughout gestation.
  • Protein S falls physiologically; antithrombin may drop in late pregnancy.
  • The growing uterus compresses pelvic veins, causing venous pooling in the legs.
  • Delivery — especially cesarean — is a major thrombosis trigger.

Risk by Thrombophilia Type

Low-risk carrier states (heterozygous FVL or PT) raise the baseline risk in pregnancy but risk is not absolute. The high-risk group: antithrombin deficiency, combined mutations, homozygous FVL and previous thrombosis. In these, prophylactic treatment is usually standard care.

Pregnancy Complications

Thrombophilia affects not only maternal veins but placental circulation:

  • Recurrent miscarriage: Particularly losses after the 10th week.
  • Preeclampsia: Associated with impaired placental vessel development.
  • Placental abruption and fetal growth restriction: Due to impaired placental flow.

Preconception Counseling

The ideal is evaluation before conception: personal and family thrombosis history, prior pregnancy complications, genetic test results and — if needed — protein/antithrombin levels. Delivery mode, prophylaxis duration and follow-up frequency are planned in this visit.

Monitoring Plan in Pregnancy

  • Every carrier receives education on DVT symptoms (unilateral leg swelling, pain).
  • In the high-risk group, low-molecular-weight heparin (LMWH) prophylaxis is planned; LMWH does not cross the placenta and does not affect the baby.
  • In low-risk carriers, prophylaxis is individualized by history and additional risk factors.
  • The postpartum period is the most critical: clot risk in the 6 weeks after delivery exceeds that of pregnancy itself; prophylaxis continues into this period when indicated.

Lifestyle Precautions

Planning pregnancy at a healthy weight, regular movement (walking, swimming), avoiding prolonged sitting, following compression stocking advice and maintaining hydration reduce risk. Smoking — which multiplies thrombosis risk in pregnancy — must be quit.

Conclusion

For carriers, pregnancy can be managed safely with correct planning. Early counseling, regular follow-up and prophylaxis when indicated give the best outcomes for mother and baby. Build your plan with your physician and our genetic counseling team.

Back to Blog

Would you like to get a thrombophilia test?

Omega Genetics Laboratory is here for you.